Amicrobe

About:

Amicrobe is an advanced biomaterials company developing product candidates for the prevention and treatment of infections.

Website: http://amicrobe.com

Top Investors: CARB-X

Description:

Amicrobe, Inc.​ is an advanced biomaterials company with innovative product candidates designed to prevent and treat infections. The Company’s new, synthetic block copolypeptides (A-Blocks) are engineered to provide broad antimicrobial activity and superior tissue coverage when our natural barriers of defense are broken in surgery, trauma / burns, and diabetic foot ulcers.

Total Funding Amount:

$14.6M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Carlsbad, California, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)amicrobe.com

Founders:

Daniel Huang, Michael P. Bevilacqua, Timothy Deming

Number of Employees:

1-10

Last Funding Date:

2020-06-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai